QTTB – q32 bio inc. (US:NASDAQ)
Stock Stats
News
Q32 Bio Inc. (NASDAQ: QTTB) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.
Q32 Bio Inc. (NASDAQ: QTTB) is now covered by analysts at SVB Leerink LLC. They set an "outperform" rating and a $54.00 price target on the stock.
Q32 Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
Q32 Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update
Seamless Therapeutics Announces New CEO and Board Chairman to Support US Expansion of Programmable Recombinase Gene Editing Technology Platform [Yahoo! Finance]
Form S-8 Q32 Bio Inc.
Form SC 13G/A Q32 Bio Inc. Filed by: ARCH Venture Fund VIII, L.P.
Form 424B3 Q32 Bio Inc.
Form 10-Q Q32 Bio Inc. For: Mar 31
Form 8-K Q32 Bio Inc. For: May 09
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.